Provided by Tiger Fintech (Singapore) Pte. Ltd.

BAIYUNSHAN PH

20.260
0.000
Volume:1.28M
Turnover:25.69M
Market Cap:32.94B
PE:10.61
High:20.280
Open:20.260
Low:19.980
Close:20.260
52wk High:20.300
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.57
T/O Rate:0.58%
Dividend:0.88
Dividend Rate:4.32%
EPS(LYR):1.910
ROE:7.97%
ROA:2.85%
PB:0.79
PE(LYR):10.61
PS:0.39

Loading ...

AH Premium Rate and Deviation Rankings as of November 13

Stock News
·
Yesterday

HK Stock Connect Shareholding Changes | November 12

Stock News
·
Nov 12

HK Stock Connect Shareholding Changes | Nov 11

Stock News
·
Nov 11

JPMorgan Increases Stake in BAIYUNSHAN PH by Approximately 267,200 Shares at HK$18.90 per Share

Deep News
·
Nov 10

JPMorgan Increases Stake in BAIYUNSHAN PH (00874) by Approximately 267,200 Shares at HK$18.9 per Share

Stock News
·
Nov 07

Southbound Capital Flow Statistics (T+2) for Hong Kong Stocks | November 5

Stock News
·
Nov 05

Guangzhou Baiyunshan (00874 HK, SSE:600332) Announces Monthly Return for October 2025

Bulletin Express
·
Nov 04

Hong Kong Stocks: 52-Week Highs and Lows as of November 3

Stock News
·
Nov 03

BAIYUNSHAN PH (00874) Rises Over 4% Post-Earnings; Q1-Q3 Net Profit Hits RMB3.31B as Wanglaoji International Cans Debut in Middle East

Stock News
·
Oct 30

广药白云山发布董事会多元化政策,强化公司可持续发展

Bulletin Express
·
Oct 28

Guangzhou Baiyunshan Pharmaceutical Holdings Announces Updated Nomination and Remuneration Committee Rules

Bulletin Express
·
Oct 28

Guangzhou Baiyunshan Pharmaceutical Holdings Announces Audit Committee Procedures

Bulletin Express
·
Oct 28

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) Releases Third Quarter 2025 Results

Bulletin Express
·
Oct 28

BAIYUNSHAN PH (00874) Reports Q3 Results: Net Profit Rises 4.78% YoY to RMB3.31 Billion

Stock News
·
Oct 28

Qingdao Chengyang Baiyun Mountain Sells Two Low-Density Land Parcels, Starting Total Price at 159 Million Yuan

Deep News
·
Oct 23

Guangzhou Baiyunshan (0874) Releases Further Details on 11.04% Equity Acquisition

Bulletin Express
·
Oct 23

Cooling Tea, Difficult Times: How Can Baiyunshan Resolve Its Profit Challenges?

Deep News
·
Oct 22

Baiyunshan: Kegangli Throat Relief Oral Solution Enters Phase III Clinical Trials

Deep News
·
Oct 19

BAIYUNSHAN PH (00874): Kengangli Yan Oral Liquid Enters Phase III Clinical Trials

Stock News
·
Oct 17

Analysis of Stock Holdings in Hong Kong Connect | October 16

Stock News
·
Oct 16